Cilag AG Company Profile

09:06 EDT 21st March 2018 | BioPortfolio



Hochstrasse 201


Phone: 41 (52) 630 9111
Fax: 41 (52) 630 9444

News Articles [12 Associated News Articles listed on BioPortfolio]

CHMP Issues A Positive Opinion On Janssen-Cilag International NV???s Zytiga To Include Earlier Stage Prostate Cancer Patients

CHMP Recommends to Broaden Indication to Include the Treatment of Men with Newly Diagnosed High-Risk Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) BEERSE, Belgium--(BUSINES...

First IL-23 targeting biologic to rival psoriasis big-sellers in EU

Janssen-Cilag International, part of the US healthcare giant Johnson & Johnson, has announced that the…

Saliva-based diagnostics offer possibility to detect HPV-induced throat cancer

This follows the extension of a QUT collaboration with Johnson & Johnson Innovation, Janssen Vaccines & Prevention, and Janssen Cilag Pty Ltd.

Janssen seeks EMA approval for Darzalex for newly diagnosed multiple myeloma

Janssen-Cilag International has submitted a Type II variation application to the European Medicines Agency (EMA), for its immunotherapy Darzalex (daratumumab).

France fines J&J 25 million Euro for blocking generics

A fine of Euros 25 million was imposed on Janssen-Cilag and its parent company Johnson & Johnson (J&J) by the French Competition Authority on 20 December 2017. This occurred in response to a r...

European Commission approves Tremfya to treat moderate to severe plaque psoriasis

Janssen-Cilag International announced that the European Commission (EC) has approved Tremfya (guselkumab) for the treatment of adults with moderate to severe plaque psoriasis who are candidates for sy...

EU Confirms Sirukumab Filing Withdrawal, J&J Moves On

Janssen-Cilag has withdrawn the EU marketing application for the IL-6 inhibitor sirukumab, with the CHMP saying the long-term safety of...    

French Competition Body Fines Janssen €25m For Delaying Generic Durogesic

Janssen-Cilag has been fined €25m by the French competition authority for running a concerted campaign to prevent generic competition to...   

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

In recent years, the anti-CD38 monoclonal antibody daratumumab (Darzalex; Janssen-Cilag Pty Ltd) has been shown to be highly efficacious in relapsed and refractory multiple myeloma, with the final res...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Efficacy and Safety of HX 575 vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients

This is a double-blind, randomized, multicenter, parallel-group, equivalence study involving about 462 clinically stable hemodialysis patients aged 18 years or above suffering from anemia ...

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

This is a randomized, double-blind, multicenter clinical phase III study involving about 105 cancer patients aged >18 years who are receiving palliative chemotherapy and who are suffering ...

Action of the Vidaza on the Atrial Fibrillation

Genomic studies on atrial fibrillation patients have identified polymorphisms in regions surrounding the PITX2 gene, suggesting it could be the locus responsible for atrial fibrillation. T...

Companies [7 Associated Companies listed on BioPortfolio]

Janssen-Cilag EMEA, EMHF, ESHA & ISG

Janssen-Cilag EMEA, a division of Janssen Pharmaceutica N.V., is a research-based pharmaceutical company that develops and markets innovative, high-quality pharmaceutical products and services aim...

Cilag AG


Janssen-Cilag AG


Janssen-Cilag Farmacéutica


Janssen-Cilag International NV

More Information about "Cilag AG" on BioPortfolio

We have published hundreds of Cilag AG news stories on BioPortfolio along with dozens of Cilag AG Clinical Trials and PubMed Articles about Cilag AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cilag AG Companies in our database. You can also find out about relevant Cilag AG Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record